Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...

6 Since we have gifts that differ according to the grace given to us, each of us is to exercise them accordingly: if prophecy, according to the proportion of his faith; 7 if service, in his serving; ...

There may have been a point, somewhere back in the middle of the last century, where the train seemed to have lost the ...

New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...

Q1 2025 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsJesse Chew - CLOSuzanne Winter ...